178 related articles for article (PubMed ID: 16891457)
1. A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats.
Garcion E; Lamprecht A; Heurtault B; Paillard A; Aubert-Pouessel A; Denizot B; Menei P; Benoît JP
Mol Cancer Ther; 2006 Jul; 5(7):1710-22. PubMed ID: 16891457
[TBL] [Abstract][Full Text] [Related]
2. A multifunctional lipid nanoparticle for co-delivery of paclitaxel and curcumin for targeted delivery and enhanced cytotoxicity in multidrug resistant breast cancer cells.
Baek JS; Cho CW
Oncotarget; 2017 May; 8(18):30369-30382. PubMed ID: 28423731
[TBL] [Abstract][Full Text] [Related]
3. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability.
Paillard A; Hindré F; Vignes-Colombeix C; Benoit JP; Garcion E
Biomaterials; 2010 Oct; 31(29):7542-54. PubMed ID: 20630585
[TBL] [Abstract][Full Text] [Related]
4. Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells.
Xu W; Bae EJ; Lee MK
Int J Nanomedicine; 2018; 13():7549-7563. PubMed ID: 30532538
[TBL] [Abstract][Full Text] [Related]
5. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
Roger E; Lagarce F; Garcion E; Benoit JP
J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.
Haga S; Hinoshita E; Ikezaki K; Fukui M; Scheffer GL; Uchiumi T; Kuwano M
Jpn J Cancer Res; 2001 Feb; 92(2):211-9. PubMed ID: 11223551
[TBL] [Abstract][Full Text] [Related]
7. Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition.
Lamprecht A; Benoit JP
J Control Release; 2006 May; 112(2):208-13. PubMed ID: 16574265
[TBL] [Abstract][Full Text] [Related]
8. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
9. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy.
Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z
Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433
[TBL] [Abstract][Full Text] [Related]
10. Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.
De Vera AA; Gupta P; Lei Z; Liao D; Narayanan S; Teng Q; Reznik SE; Chen ZS
Cancer Lett; 2019 Feb; 442():91-103. PubMed ID: 30391357
[TBL] [Abstract][Full Text] [Related]
11. A Smart Paclitaxel-Disulfiram Nanococrystals for Efficient MDR Reversal and Enhanced Apoptosis.
Mohammad IS; He W; Yin L
Pharm Res; 2018 Feb; 35(4):77. PubMed ID: 29488114
[TBL] [Abstract][Full Text] [Related]
12. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
[TBL] [Abstract][Full Text] [Related]
13. Long-chain polyunsaturated fatty acids promote paclitaxel cytotoxicity via inhibition of the MDR1 gene in the human colon cancer Caco-2 cell line.
Kuan CY; Walker TH; Luo PG; Chen CF
J Am Coll Nutr; 2011 Aug; 30(4):265-73. PubMed ID: 21917707
[TBL] [Abstract][Full Text] [Related]
14. Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression.
Liao D; Zhang W; Gupta P; Lei ZN; Wang JQ; Cai CY; Vera AA; Zhang L; Chen ZS; Yang DH
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801248
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
Valsalakumari R; Yadava SK; Szwed M; Pandya AD; Mælandsmo GM; Torgersen ML; Iversen TG; Skotland T; Sandvig K; Giri J
Int J Pharm; 2021 Mar; 597():120217. PubMed ID: 33486035
[TBL] [Abstract][Full Text] [Related]
16. Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model.
Allard E; Huynh NT; Vessières A; Pigeon P; Jaouen G; Benoit JP; Passirani C
Int J Pharm; 2009 Sep; 379(2):317-23. PubMed ID: 19467309
[TBL] [Abstract][Full Text] [Related]
17. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological strategies for overcoming multidrug resistance.
Nobili S; Landini I; Giglioni B; Mini E
Curr Drug Targets; 2006 Jul; 7(7):861-79. PubMed ID: 16842217
[TBL] [Abstract][Full Text] [Related]
19. Trametenolic acid B reverses multidrug resistance in breast cancer cells through regulating the expression level of P-glycoprotein.
Zhang Q; Wang J; He H; Liu H; Yan X; Zou K
Phytother Res; 2014 Jul; 28(7):1037-44. PubMed ID: 25289403
[TBL] [Abstract][Full Text] [Related]
20. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X
Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
